Pharmaceutical Executive-10-22-2009

Pharmaceutical Executive

Pfizer Profits Spike as Wyeth Deal is Finalized

October 21, 2009

0

0

The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?